Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 401–450 of 1,961 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04300855	Clinical Trial of Green Tea Catechins in Men on Active Surveillance	active not recruiting	Phase 2	115	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Apr 1, 2026	clinicaltrials
NCT07259213	A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC(RAD402)	recruiting	Phase 1 / Phase 2	73	Radiopharm Theranostics, LtdINDUSTRY	1	Apr 1, 2026